Adipose zinc‐α2‐glycoprotein is a catabolic marker in cancer and noncancerous states

Mikael Rydén(Karolinska University Hospital), Peter Arner(Karolinska University Hospital), Thorhallur Agustsson(Karolinska University Hospital), Jan Bolinder(Karolinska University Hospital), Eva Toft(Ersta sjukhus), Jonas Andersson(Skellefteå Hospital)
Journal of Internal Medicine
September 1, 2011
10.1111/j.1365-2796.2011.02441.x
Cited by 37

Related Papers

SCORE2 risk prediction algorithms: new models to estimate 10-year risk of cardiovascular disease in Europe
|European Heart Journal|2021|1.7k
Comprehensive human cell-type methylation atlas reveals origins of circulating cell-free DNA in health and disease
|Nature Communications|2018|1k
Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections
|JAMA|2017|689
A DNA methylation atlas of normal human cell types
|Nature|2023|620
Outcomes 1 Year after Thrombus Aspiration for Myocardial Infarction
|New England Journal of Medicine|2014|395